4.7 Review

NCL diseases - clinical perspectives

期刊

出版社

ELSEVIER
DOI: 10.1016/j.bbadis.2013.04.008

关键词

Batten; Ceroid; NCLs; Disease classification; Diagnostic algorithm

资金

  1. European Union [281234]

向作者/读者索取更多资源

The neuronal ceroid lipofuscinoses (NCLs) are lysosomal storage disorders and together are the most common degenerative brain diseases in childhood. They are a group of disorders linked by the characteristic accumulation of abnormal storage material in neurons and other cell types, and a degenerative disease course. All NCLs are characterized by a combination of dementia, epilepsy, and motor decline. For most childhood NCLs, a progressive visual failure is also a core feature. The characteristics of these symptoms can vary and the age at disease onset ranges from birth to young adulthood. Genetic heterogeneity, with fourteen identified NCL genes and wide phenotypic variability render diagnosis difficult. A new NCL classification system based on the affected gene and the age at disease onset allows a precise and practical delineation of an individual patient's NCL type. A diagnostic algorithm to identify each NCL form is presented here. Precise NCL diagnosis is essential not only for genetic counseling, but also for the optimal delivery of care and information sharing with the family and other caregivers. These aspects are challenging because there are also potential long term complications which are specific to NCL type. Therefore care supported by a specifically experienced team of clinicians is recommended. As the underlying pathophysiological mechanism is still unclear for all NCL forms, the development of curative therapies remains difficult. This article is part of a Special Issue entitled: The neuronal ceroid lipofuscinoses or Batten Disease. (C) 2013 Published by Elsevier B.V.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Megalencephalic leukoencephalopathy with subcortical cysts Characterization of disease variants

Eline M. C. Hamilton, Pinar Tekturk, Fia Cialdella, Diane F. van Rappard, Nicole I. Wolf, Cengiz Yalcinkaya, Umran Cetincelik, Ahmad Rajaee, Ariana Kariminejad, Justyna Paprocka, Zuhal Yapici, Vlatka Mejaski Bosnjak, Marjo S. van der Knaap

NEUROLOGY (2018)

Article Medicine, General & Internal

Study of Intraventricular Cerliponase Alfa for CLN2 Disease

Angela Schulz, Temitayo Ajayi, Nicola Specchio, Emily de Los Reyes, Paul Gissen, Douglas Ballon, Jonathan P. Dyke, Heather Cahan, Peter Slasor, David Jacoby, Alfried Kohlschutter

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Clinical Neurology

Autophagic vacuolar myopathy is a common feature of CLN3 disease

Josefine Radke, Randi Koll, Esther Gill, Lars Wiese, Angela Schulz, Alfried Kohlschuetter, Markus Schuelke, Christian Hagel, Werner Stenzel, Hans H. Goebel

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)

Article Clinical Neurology

Current and Emerging Treatment Strategies for Neuronal Ceroid Lipofuscinoses

Alfried Kohlschuetter, Angela Schulz, Udo Bartsch, Stephan Storch

CNS DRUGS (2019)

Meeting Abstract Endocrinology & Metabolism

Twelve-year experience with a rapid and simple fluorometric tripeptidyl peptidase I (TPPI) assay using dried blood specimens to diagnose CLN2 disease

Zoltan Lukacs, Miriam Nickel, Simona Murko, Paulina Nieves Cobos, Angela Schulz, Rene Santer, Alfried Kohlschuetter

MOLECULAR GENETICS AND METABOLISM (2019)

Article Medical Laboratory Technology

Validity of a rapid and simple fluorometric tripeptidyl peptidase 1(TPP1) assay using dried blood specimens to diagnose CLN2 disease

Zoltan Lukacs, Miriam Nickel, Simona Murko, Paulina Nieves Cobos, Angela Schulz, Rene Santer, Alfried Kohlschuetter

CLINICA CHIMICA ACTA (2019)

Article Clinical Neurology

First Recognized Patient with Genetic Vitamin E Deficiency Stable after 36 Years of Controlled Supplement Therapy

Alfried Kohlschuetter, Barbara Finckh, Miriam Nickel, Annette Bley, Christoph Huebner

NEURODEGENERATIVE DISEASES (2020)

Article Biochemical Research Methods

Enzymatic diagnosis of neuronal lipofuscinoses in dried blood spots using substrates for concomitant tandem mass spectrometry and fluorimetry

Stefan Maeser, Brindusa-Alina Petre, Laura Ion, Stephan Rawer, Alfried Kohlschuetter, Filippo M. Santorelli, Alessandro Simonati, Angela Schulz, Michael Przybylski

Summary: The study aimed to develop specific and sensitive diagnostic assays for NCLs, especially with the emergence of enzyme replacement therapy for NCL2 in clinical treatment and ongoing development for other NCLs.

JOURNAL OF MASS SPECTROMETRY (2021)

Article Ophthalmology

Ophthalmological manifestations of neuronal ceroid lipofuscinoses (NCL) NCL as diseases of brain and retina-the role of ophthalmologists

Yevgeniya Atiskova, Alfried Kohlschutter, Martin Stephan Spitzer, Simon Dulz

Summary: Neuronal ceroid lipofuscinoses are inherited lysosomal storage diseases that can result in progressive neurodegeneration. Visual decline may be the initial symptom, and early diagnosis is crucial for personal and family planning as well as therapeutic strategies. Collaboration with neuropediatricians is recommended when retinal degeneration due to an NCL disease is suspected.

OPHTHALMOLOGE (2021)

Article Multidisciplinary Sciences

Genetic testing of leukodystrophies unraveling extensive heterogeneity in a large cohort and report of five common diseases and 38 novel variants

Nejat Mahdieh, Mahdieh Soveizi, Ali Reza Tavasoli, Ali Rabbani, Mahmoud Reza Ashrafi, Alfried Kohlschuetter, Bahareh Rabbani

Summary: This study evaluated the genetic spectrum of leukodystrophies and leukoencephalopathies in Iran, identifying 35 different types of genetic disorders. Genetic analysis at earlier stages of the disease can reduce uncertainty, costs, and provide basis for genetic counseling and family planning.

SCIENTIFIC REPORTS (2021)

Article Genetics & Heredity

The natural history of Canavan disease: 23 new cases and comparison with patients from literature

Annette Bley, Jonas Denecke, Alfried Kohlschuetter, Gerhard Schoen, Sandra Hischke, Philipp Guder, Tatjana Bierhals, Heather Lau, Maja Hempel, Florian S. Eichler

Summary: Canavan disease is a rare and devastating leukodystrophy of early childhood with onset of symptoms between 0-6 months. The early hallmarks of the disease include severe psychomotor disability and macrocephaly developing within the first 18 months of life. Seizures become more frequent over time in most patients. Ethnically, CD occurs more frequently outside Ashkenazi Jewish communities than previously reported, and a CD severity score has been developed for assessment of disease severity.

ORPHANET JOURNAL OF RARE DISEASES (2021)

Review Clinical Neurology

Ethical Issues in Care and Treatment of Neuronal Ceroid Lipofuscinoses (NCL)-A Personal View

Alfried Kohlschuetter

Summary: The management of Neuronal Ceroid Lipofuscinoses (NCL) presents ethical dilemmas in terms of patient care and treatment decisions, with concerns about end-of-life care planning and potential risks associated with novel therapies. Careful evaluation and consideration of risks and benefits are essential in addressing these ethical issues in the context of rare progressive brain diseases like NCL.

FRONTIERS IN NEUROLOGY (2021)

Article Health Policy & Services

Early diagnosis of a rare disease in children through better communication between parents, physicians and academic centers

Alfried Kohlschuetter, Hendrik van den Bussche

ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN (2019)

Article Clinical Neurology

A recurrent de novo mutation in TMEM106B causes hypomyelinating leukodystrophy

Cas Simons, David Dyment, Stephen J. Bent, Joanna Crawford, Marc D'Hooghe, Alfried Kohlschuetter, Sunita Venkateswaran, Guy Helman, Bwee-Tien Poll-The, Christine C. Makowski, Yoko Ito, Kristin Kernohan, Taila Hartley, Quinten Waisfisz, Ryan J. Taft, Marjo S. van der Knaap, Nicole I. Wolf

Article Pediatrics

Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study

Miriam Nickel, Alessandro Simonati, David Jacoby, Susanne Lezius, Dirk Kilian, Benjamin Van de Graaf, Odelya E. Pagovich, Barry Kosofsky, Kaleb Yohay, Matthew Downs, Peter Slasor, Temitayo Aiayi, Ronald G. Crystal, Alfried Kohlschuetter, Dolan Sondhi, Angela Schulz

LANCET CHILD & ADOLESCENT HEALTH (2018)

Review Biochemistry & Molecular Biology

A mitochondrial nexus in major depressive disorder: Integration with the psycho-immune-neuroendocrine network

M. T. Ciubuc-Batcu, N. J. C. Stapelberg, J. P. Headrick, G. M. C. Renshaw

Summary: The nervous system relies on mitochondria, and impaired mitochondrial function is associated with major depressive disorder. Modulating mitochondrial function may be a therapeutic target for treating MDD.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Correction Biochemistry & Molecular Biology

Diminishing acetyl-CoA carboxylase 1 attenuates CCA migration via AMPK-NF-κB-snail axis (vol 1869, 166694, 2023)

Saowaluk Saisomboon, Ryusho Kariya, Piyanard Boonnate, Kanlayanee Sawanyawisuth, Ubon Cha'on, Vor Luvira, Yaovalux Chamgramol, Chawalit Pairojkul, Wunchana Seubwai, Atit Silsirivanit, Sopit Wongkham, Seiji Okada, Sarawut Jitrapakdee, Kulthida Vaeteewoottacharn

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

Humanin ameliorates TBI-related cognitive impairment by attenuating mitochondrial dysfunction and inflammation

Pavan Thapak, Zhe Ying, Victoria Palafox-Sanchez, Guanglin Zhang, Xia Yang, Fernando Gomez-Pinilla

Summary: Traumatic brain injury (TBI) impairs cellular energy demand, compromising neuronal function and plasticity. This study demonstrates that the mitochondrial activator humanin (HN) can counteract the reduction in mitochondrial bioenergetics caused by TBI, restore memory function and synaptic protein levels, and suppress inflammation and astrocyte proliferation. HN plays an integral role in normalizing fundamental aspects of TBI pathology.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

The amyloid-β peptide: Guilty as charged?

M. Paul Murphy, Valeria A. Buzinova, Carrie E. Johnson

Summary: Progress has been made in the treatment of Alzheimer's disease through the development of anti-A beta therapeutics, which have shown modest efficacy in slowing the progression of the disease. However, the puzzling issue remains as to why completely removing A beta does not fully stop the disease.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Review Biochemistry & Molecular Biology

Reactive oxygen species in colorectal cancer adjuvant therapies

Yang Zhang, Mengqiu Hao, Xuyang Yang, Su Zhang, Junhong Han, Ziqiang Wang, Hai-Ning Chen

Summary: Colorectal cancer often requires adjuvant therapies to reduce tumor burden, and the efficacy of these therapies is significantly influenced by reactive oxygen species (ROS). ROS-mediated colorectal cancer adjuvant therapies involve multiple mechanisms, and preliminary clinical trials have shown the potential of ROS-manipulating therapy in enhancing treatment outcomes.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

GK921, a transglutaminase inhibitor, strengthens the antitumor effect of cisplatin on pancreatic cancer cells by inhibiting epithelial-to-mesenchymal transition

Mengxin Li, Xuanzhong Wang, Xuyang Chen, Jinghui Hong, Ye Du, Dong Song

Summary: Pancreatic adenocarcinoma (PAAD) is a common digestive malignant tumor with limited treatment options. This study demonstrates that TGM2 may serve as a marker for treatment and prognosis in pancreatic cancer patients. Co-treatment of low dose cisplatin (DDP) and the TGM2 inhibitor GK921 effectively inhibits PAAD cell viability and proliferation in vitro and in vivo, by inhibiting epithelial-to-mesenchymal transition (EMT) induced by TGM2 and enhancing cell cycle arrest and apoptosis caused by DDP. These findings suggest that the combination of GK921 and DDP holds promise as a treatment for PAAD patients.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

Small extracellular vesicles-mediated cellular interactions between tumor cells and tumor-associated macrophages: Implication for immunotherapy

Liaoran Niu, Qi Wang, Fan Feng, Wanli Yang, Zhenyu Xie, Gaozan Zheng, Wei Zhou, Lili Duan, Kunli Du, Yiding Li, Ye Tian, Junfeng Chen, Qibin Xie, Aqiang Fan, Hanjun Dan, Jinqiang Liu, Daiming Fan, Liu Hong, Jian Zhang, Jianyong Zheng

Summary: This review provides a comprehensive summary of the interaction between cancer cells and macrophages in the tumor microenvironment, and discusses the role of small extracellular vesicles (sEVs) in this process. It also explores the various effects of macrophage-secreted sEVs on tumor malignant transformation, and addresses the therapeutic advancements and challenges associated with these vesicles.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

Protective effects of SSRI, Citalopram in mutant APP and mutant Tau expressed dorsal raphe neurons in Alzheimer's disease

Neha Sawant, Sudhir Kshirsagar, P. Hemachandra Reddy, Arubala P. Reddy

Summary: Depression is a common neuropsychiatric comorbidity in Alzheimer's disease (AD) and other Tauopathies. Selective serotonin reuptake inhibitor (SSRI) treatment, such as Citalopram, not only has anti-depressive and anxiolytic effects, but also helps improve neurogenesis, reduce amyloid burden & Tau pathologies, and neuroinflammation in AD. In this study, Citalopram was found to reduce pathologically pTau level, increase synaptic gene expression and cytoskeletal structure, as well as improve cell survival, mitochondrial respiration, and mitochondrial morphology in cells expressing mutant APP and Tau. These findings suggest that Citalopram could be a promising therapeutic drug for treating depression and AD.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

Dynamic chromatin accessibility landscapes of osteoblast differentiation and mineralization

Yueqi Chen, Jiulin Tan, Chuan Yang, Zhiguo Ling, Jianzhong Xu, Dong Sun, Fei Luo

Summary: Bone is a self-healing organ that undergoes continuous regeneration through the cooperation of osteoclasts and osteoblasts. This study used ATAC-seq and RNA-Seq techniques to investigate the chromatin accessibility and transcriptomic landscape of osteoblast differentiation and mineralization. The results showed that global chromatin accessibility was extensively improved during osteoblastogenesis. Additionally, several transcription factors including MEF2A, PRRX1, Shox2, and HOXB13 were found to modulate the promoter accessibility of target genes during osteoblast differentiation.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

Deficiency of BCAT2-mediated branched-chain amino acid catabolism promotes colorectal cancer development

Zi-Ran Kang, Shanshan Jiang, Ji-Xuan Han, Yaqi Gao, Yile Xie, Jinxian Chen, Qiang Liu, Jun Yu, Xin Zhao, Jie Hong, Haoyan Chen, Ying-Xuan Chen, Huimin Chen, Jing-Yuan Fang

Summary: The study demonstrates that BCAA metabolism is involved in the development of colorectal cancer (CRC). BCAT2 deficiency promotes CRC progression by inhibiting BCAA metabolism and chronically activating the mTORC1 pathway.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

Alleviation of experimental autoimmune encephalomyelitis by transferring low RelB expression tolerogenic dendritic cells

Chao Zheng, Lingling Liu, Caiyun Liu, Fengna Chu, Yue Lang, Shan Liu, Yan Mi, Jie Zhu, Tao Jin

Summary: Inducing tolerogenic dendritic cells (tDCs) with low RelB expression could effectively alleviate symptoms and reduce immune cell infiltration and demyelination in experimental autoimmune encephalomyelitis (EAE) mouse model.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

Soluble adenylyl cyclase, the cell-autonomous member of the family

Hang Lam Li, Simei Go, Jung-Chin Chang, Arthur Verhoeven, Ronald Oude Elferink

Summary: This review highlights the distinct characteristics and crucial role of soluble adenylyl cyclase (sAC) in cellular processes, as well as recent significant advancements in the field of sAC research.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

Resistance to apoptosis in complicated Crohn's disease: Relevance in ileal fibrosis

M. Seco-Cervera, D. Ortiz-Masia, D. C. Macias-Ceja, S. Coll, L. Gisbert-Ferrandiz, J. Cosin-Roger, C. Bauset, M. Ortega, B. Heras-Moran, F. Navarro-Vicente, M. Millan, J. V. Esplugues, S. Calatayud, M. D. Barrachina

Summary: The study revealed the presence of resistance to apoptosis in complicated ileal Crohn's disease, with PDGFB inducing an ETS1-mediated resistance to apoptosis associated with an inflammatory and fibrogenic pattern of expression in intestinal fibroblasts. Potential targets against ileal fibrosis include PDGFRB, IL1R1, or MCL1.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Review Biochemistry & Molecular Biology

Arming oncolytic viruses with bispecific T cell engagers: The evolution and current status

Yunmeng Wang, Ping Cheng

Summary: Oncolytic viruses (OVs) are emerging as therapeutically relevant anticancer agents, especially when combined with genetically modified bispecific T cell engagers (BiTEs). This combination strategy can overcome the limitations of BiTEs alone and provide targeted cytotoxicity to solid tumors.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

Impaired digestive function of sucrase-isomaltase in a complex with the Greenlandic sucrase-isomaltase variant

Stephanie Tannous, Hassan Y. Naim

Summary: Congenital sucrase-isomaltase deficiency (CSID) is an autosomal recessive disorder caused by variants in the SI gene. A frameshift mutation called c.273_274delAG (p.Gly92Leufs*8) has been identified in CSID patients in Greenlandic population, which leads to loss of digestive function of SI. Surprisingly, the truncated mutant can still be located on the cell surface and interacts with wild type SI, negatively affecting its enzymatic function. Furthermore, heterozygote carriers of this mutation may also exhibit CSID symptoms.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)